Drugs chief replaces long-serving CEO Vasella
New CEO says to maintain strategy
* Considers bid for Alcon minorities as fair
* Q4 net profit $2.3 billion vs forecast $2.4 billion
* Shares up 1.5 percent
See more ›
Drugs chief replaces long-serving CEO Vasella
New CEO says to maintain strategy
* Considers bid for Alcon minorities as fair
* Q4 net profit $2.3 billion vs forecast $2.4 billion
* Shares up 1.5 percent
See more ›